MK2 inhibition with MMI-0100 after acute myocardial infarction inhibited cardiac fibrosis by enhancing primary cardiac fibroblast cell death while inhibiting cardiomyocyte apoptosis [73]. The gene discussed is MAPKAPK2; the disease is myocardial infarction.